US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist

2.8400
-0.0100-0.35%

Close Jul 19 16:00 ET

26.21MMarket Cap-422P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

53.89%11.39M

31.67%38.08M

140.12%18.87M

-31.82%5.32M

-1.01%6.48M

10.36%7.4M

115.91%28.92M

7.02%7.86M

95.65%7.81M

127.78%6.54M

Selling and administrative expenses

21.52%4.19M

45.27%23.8M

416.22%14.88M

-36.44%2.57M

-32.70%2.9M

-33.53%3.45M

-4.11%16.38M

-62.82%2.88M

12.31%4.04M

79.65%4.31M

-General and administrative expense

21.52%4.19M

45.27%23.8M

416.22%14.88M

-36.44%2.57M

-32.70%2.9M

-33.53%3.45M

-4.11%16.38M

-62.82%2.88M

12.31%4.04M

79.65%4.31M

Research and development costs

79.60%8.15M

-54.68%16.52M

-39.80%4.3M

-45.33%4.02M

-57.34%3.66M

-65.96%4.54M

-36.28%36.44M

-32.96%7.14M

-51.21%7.35M

-54.05%8.58M

Other operating expenses

-62.55%-944.58K

90.63%-2.24M

85.88%-305.01K

64.69%-1.27M

98.65%-85.52K

95.08%-581.1K

60.73%-23.9M

80.46%-2.16M

75.55%-3.59M

65.13%-6.35M

Operating profit

-53.89%-11.39M

-31.67%-38.08M

-140.12%-18.87M

31.82%-5.32M

1.01%-6.48M

-245.26%-7.4M

-115.91%-28.92M

-7.02%-7.86M

-95.65%-7.81M

-127.78%-6.54M

Net non-operating interest income expense

1,325.46%421.52K

216.99%269.68K

803.08%406.17K

-3.93%-55.34K

15.63%-46.75K

46.33%-34.4K

15.05%-230.51K

-0.07%-57.77K

28.81%-53.24K

19.85%-55.41K

Non-operating interest income

758.61%497.89K

723.06%584.97K

1,517.31%484.05K

-17.38%14.36K

80.54%28.57K

630.97%57.99K

207.47%71.07K

250.29%29.93K

361.26%17.39K

198.79%15.82K

Non-operating interest expense

-17.33%76.37K

4.54%315.28K

-11.20%77.88K

-1.31%69.7K

5.73%75.32K

28.27%92.39K

2.42%301.58K

32.33%87.7K

-10.10%70.63K

-4.30%71.24K

Other net income (expense)

7,096.56%5.94M

-142.06%-4.39M

-6,478.39%-4.39M

-64.83%275.94K

-120.66%-357.52K

-98.95%82.59K

399.80%10.43M

101.66%68.81K

19,745.41%784.49K

1.73M

Gain on sale of security

6,521.24%5.47M

-146.38%-4.82M

-13,020.42%-4.73M

-77.17%178.76K

-120.66%-357.52K

-98.95%82.59K

350.52%10.4M

--36.59K

--782.96K

--1.73M

Other non- operating income (expenses)

--475.13K

1,189.00%435.09K

948.52%337.91K

6,264.31%97.18K

----

515.05%33.75K

1,999.48%32.23K

-61.37%1.53K

----

Income before tax

31.66%-5.03M

-125.45%-42.19M

-191.21%-22.86M

27.89%-5.1M

-41.34%-6.88M

-782.08%-7.35M

-9.16%-18.72M

32.05%-7.85M

-74.24%-7.08M

-65.49%-4.87M

Income tax

25.63K

-92.28K

Net income

31.66%-5.03M

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

-74.24%-7.08M

-62.36%-4.78M

Net income continuous Operations

31.66%-5.03M

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

-74.24%-7.08M

-62.36%-4.78M

Minority interest income

Net income attributable to the parent company

31.66%-5.03M

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

-74.24%-7.08M

-62.36%-4.78M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

31.66%-5.03M

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

-74.24%-7.08M

-62.36%-4.78M

Basic earnings per share

63.01%-0.54

-77.26%-7.64

-112.15%-3.84

37.50%-1

-27.27%-1.4

-830.00%-1.46

31.59%-4.31

31.86%-1.81

-71.28%-1.6

-62.57%-1.1

Diluted earnings per share

63.01%-0.54

-77.26%-7.64

-112.15%-3.84

37.50%-1

-27.27%-1.4

-830.00%-1.46

31.59%-4.31

31.86%-1.81

-71.28%-1.6

-62.57%-1.1

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	53.89%11.39M	31.67%38.08M	140.12%18.87M	-31.82%5.32M	-1.01%6.48M	10.36%7.4M	115.91%28.92M	7.02%7.86M	95.65%7.81M	127.78%6.54M
Selling and administrative expenses	21.52%4.19M	45.27%23.8M	416.22%14.88M	-36.44%2.57M	-32.70%2.9M	-33.53%3.45M	-4.11%16.38M	-62.82%2.88M	12.31%4.04M	79.65%4.31M
-General and administrative expense	21.52%4.19M	45.27%23.8M	416.22%14.88M	-36.44%2.57M	-32.70%2.9M	-33.53%3.45M	-4.11%16.38M	-62.82%2.88M	12.31%4.04M	79.65%4.31M
Research and development costs	79.60%8.15M	-54.68%16.52M	-39.80%4.3M	-45.33%4.02M	-57.34%3.66M	-65.96%4.54M	-36.28%36.44M	-32.96%7.14M	-51.21%7.35M	-54.05%8.58M
Other operating expenses	-62.55%-944.58K	90.63%-2.24M	85.88%-305.01K	64.69%-1.27M	98.65%-85.52K	95.08%-581.1K	60.73%-23.9M	80.46%-2.16M	75.55%-3.59M	65.13%-6.35M
Operating profit	-53.89%-11.39M	-31.67%-38.08M	-140.12%-18.87M	31.82%-5.32M	1.01%-6.48M	-245.26%-7.4M	-115.91%-28.92M	-7.02%-7.86M	-95.65%-7.81M	-127.78%-6.54M
Net non-operating interest income expense	1,325.46%421.52K	216.99%269.68K	803.08%406.17K	-3.93%-55.34K	15.63%-46.75K	46.33%-34.4K	15.05%-230.51K	-0.07%-57.77K	28.81%-53.24K	19.85%-55.41K
Non-operating interest income	758.61%497.89K	723.06%584.97K	1,517.31%484.05K	-17.38%14.36K	80.54%28.57K	630.97%57.99K	207.47%71.07K	250.29%29.93K	361.26%17.39K	198.79%15.82K
Non-operating interest expense	-17.33%76.37K	4.54%315.28K	-11.20%77.88K	-1.31%69.7K	5.73%75.32K	28.27%92.39K	2.42%301.58K	32.33%87.7K	-10.10%70.63K	-4.30%71.24K
Other net income (expense)	7,096.56%5.94M	-142.06%-4.39M	-6,478.39%-4.39M	-64.83%275.94K	-120.66%-357.52K	-98.95%82.59K	399.80%10.43M	101.66%68.81K	19,745.41%784.49K	1.73M
Gain on sale of security	6,521.24%5.47M	-146.38%-4.82M	-13,020.42%-4.73M	-77.17%178.76K	-120.66%-357.52K	-98.95%82.59K	350.52%10.4M	--36.59K	--782.96K	--1.73M
Other non- operating income (expenses)	--475.13K	1,189.00%435.09K	948.52%337.91K	6,264.31%97.18K	----	----	515.05%33.75K	1,999.48%32.23K	-61.37%1.53K	----
Income before tax	31.66%-5.03M	-125.45%-42.19M	-191.21%-22.86M	27.89%-5.1M	-41.34%-6.88M	-782.08%-7.35M	-9.16%-18.72M	32.05%-7.85M	-74.24%-7.08M	-65.49%-4.87M
Income tax		0			0		25.63K			-92.28K
Net income	31.66%-5.03M	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M	-74.24%-7.08M	-62.36%-4.78M
Net income continuous Operations	31.66%-5.03M	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M	-74.24%-7.08M	-62.36%-4.78M
Minority interest income
Net income attributable to the parent company	31.66%-5.03M	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M	-74.24%-7.08M	-62.36%-4.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	31.66%-5.03M	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M	-74.24%-7.08M	-62.36%-4.78M
Basic earnings per share	63.01%-0.54	-77.26%-7.64	-112.15%-3.84	37.50%-1	-27.27%-1.4	-830.00%-1.46	31.59%-4.31	31.86%-1.81	-71.28%-1.6	-62.57%-1.1
Diluted earnings per share	63.01%-0.54	-77.26%-7.64	-112.15%-3.84	37.50%-1	-27.27%-1.4	-830.00%-1.46	31.59%-4.31	31.86%-1.81	-71.28%-1.6	-62.57%-1.1
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall